AbbVie submits European MAA for risankizumab in moderate to severe plaque psoriasis May 2, 2018 No Comments
EMA committee hands down positive opinion for Cimzia in moderate to severe plaque psoriasis April 30, 2018 No Comments
AbbVie submits BLA to the FDA for risankizumab in moderate to severe plaque psoriasis April 26, 2018 No Comments
Phase II ATOMIK study of serlopitant does not meet primary or key secondary efficacy endpoints April 9, 2018 No Comments
Krystal files IND with FDA for phase I/II study of KB-103 for dystrophic EB March 28, 2018 No Comments
Genentech develops anti-inflammatory nuclear receptor ROR-gamma inverse agonists March 26, 2018 No Comments
Bristol-Myers Squibb discovers new Toll-like receptor 7, 8 and 9 antagonists March 26, 2018 No Comments
RSS